Holen Sie sich die Stockscreener-App
7.05
4.37%
0.295
Schlusskurs vom Vortag:
$6.755
Offen:
$6.73
24-Stunden-Volumen:
1.83M
Relative Volume:
0.69
Marktkapitalisierung:
$1.18B
Einnahmen:
$93.95M
Nettoeinkommen (Verlust:
$-129.87M
KGV:
-7.8333
EPS:
-0.9
Netto-Cashflow:
$-202.88M
1W Leistung:
-0.42%
1M Leistung:
-10.19%
6M Leistung:
+16.72%
1J Leistung:
-50.87%
1-Tages-Spanne:
$6.67
$7.08
1-Wochen-Bereich:
$6.60
$7.38
52-Wochen-Spanne:
$5.28
$16.38
Wave Life Sciences Ltd Stock (WVE) Company Profile
Firmenname
Wave Life Sciences Ltd
Sektor
Branche
Telefon
617-949-2900
Adresse
7 STRAITS VIEW, SINGAPORE
Vergleichen Sie WVE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
WVE
Wave Life Sciences Ltd
|
7.05 | 1.13B | 93.95M | -129.87M | -202.88M | -0.90 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-20 | Eingeleitet | Wells Fargo | Overweight |
| 2025-08-04 | Eingeleitet | Canaccord Genuity | Buy |
| 2025-07-28 | Eingeleitet | Oppenheimer | Outperform |
| 2025-07-16 | Eingeleitet | Citigroup | Buy |
| 2025-06-11 | Fortgesetzt | Raymond James | Outperform |
| 2025-04-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-04-08 | Eingeleitet | Wedbush | Outperform |
| 2025-02-25 | Eingeleitet | Jefferies | Buy |
| 2024-10-16 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-09-27 | Fortgesetzt | JP Morgan | Overweight |
| 2024-09-19 | Eingeleitet | B. Riley Securities | Buy |
| 2024-09-09 | Eingeleitet | JP Morgan | Overweight |
| 2024-05-15 | Eingeleitet | Wells Fargo | Overweight |
| 2023-12-19 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2023-07-05 | Eingeleitet | Raymond James | Outperform |
| 2023-05-24 | Herabstufung | Jefferies | Buy → Hold |
| 2020-12-15 | Fortgesetzt | H.C. Wainwright | Buy |
| 2020-10-23 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2019-12-31 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2019-11-01 | Eingeleitet | Guggenheim | Buy |
| 2019-07-15 | Eingeleitet | Cowen | Market Perform |
| 2019-04-17 | Bestätigt | H.C. Wainwright | Buy |
| 2018-08-07 | Eingeleitet | Stifel | Buy |
| 2018-07-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-03-19 | Bestätigt | Mizuho | Buy |
| 2017-02-15 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-11-10 | Fortgesetzt | Leerink Partners | Outperform |
| 2015-12-07 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2015-12-07 | Eingeleitet | Jefferies | Buy |
| 2015-12-07 | Eingeleitet | Leerink Partners | Outperform |
| 2015-12-07 | Eingeleitet | Sun Trust Rbsn Humphrey | Buy |
Alle ansehen
Wave Life Sciences Ltd Aktie (WVE) Neueste Nachrichten
Wave Life Sciences (WVE): A Closer Look at Valuation After a Volatile Start to 2024 - simplywall.st
Understanding Momentum Shifts in (WVE) - news.stocktradersdaily.com
Candlestick signals on Wave Life Sciences Ltd. stock todayQuarterly Trade Report & AI Driven Stock Movement Reports - newser.com
Why Wave Life Sciences Ltd. (1U5) stock gets analyst attentionPortfolio Gains Summary & Fast Gain Swing Trade Alerts - newser.com
How Will Wave Life Sciences' (WVE) Enhanced RNA Platform Shape Its Investment Appeal? - simplywall.st
Wave Life Sciences at Jefferies London: RNA Medicine Advancements By Investing.com - Investing.com Australia
Can Wave Life Sciences Ltd. (1U5) stock withstand sector downturns2025 Trading Volume Trends & Expert Approved Momentum Trade Ideas - newser.com
Can Wave Life Sciences Ltd. rally from current levelsAnalyst Upgrade & Reliable Intraday Trade Alerts - newser.com
How reliable is Wave Life Sciences Ltd. (1U5) stock dividend growthSell Signal & Weekly Return Optimization Alerts - newser.com
Will Wave Life Sciences Ltd. (1U5) stock benefit from infrastructure billGDP Growth & Verified Trade Idea Suggestions - newser.com
Heatmap analysis for Wave Life Sciences Ltd. and competitorsDip Buying & Free Fast Entry Momentum Trade Alerts - newser.com
Can Wave Life Sciences Ltd. (1U5) stock hold up in economic slowdownIPO Watch & Free Weekly Chart Analysis and Trade Guides - newser.com
Wave Life Sciences Hits Day High with Strong 7.2% Intraday Surge - Markets Mojo
Can Wave Life Sciences Ltd. (1U5) stock expand revenue streamsWeekly Loss Report & Verified Momentum Stock Ideas - newser.com
What insider trading reveals about Wave Life Sciences Ltd. stockLayoff News & Accurate Intraday Trading Signals - newser.com
Why Wave Life Sciences Ltd. stock appeals to analystsWeekly Profit Report & Community Driven Trade Alerts - newser.com
Wave Life Sciences Highlights RNA Platform Advancements - TipRanks
Is Wave Life Sciences Ltd. meeting your algorithmic filter criteriaVolume Spike & Weekly Watchlist for Consistent Profits - newser.com
Wave Life Sciences Ltd Updates Corporate Presentation - TradingView
Jefferies Maintains "Buy" Rating on Wave Life Sciences (WVE) Amid Its Improving Competitive Positioning - Finviz
Jefferies Maintains “Buy” Rating on Wave Life Sciences (WVE) Amid Its Improving Competitive Positioning - MSN
Can Wave Life Sciences Ltd. recover in the next quarterTrade Signal Summary & Safe Entry Zone Identification - newser.com
How Wave Life Sciences Ltd. stock compares to market leadersJuly 2025 Drop Watch & Accurate Buy Signal Alerts - newser.com
Ra Capital buys $6.7k in Wave Life Sciences (WVE) shares By Investing.com - Investing.com South Africa
10 Best Small-Cap Biotech Stocks to Buy According to Analysts - Insider Monkey
Ra Capital buys $6.7k in Wave Life Sciences (WVE) shares - Investing.com Nigeria
Insider Sell: Adrian Rawcliffe Sells Shares of WAVE Life Sciences Ltd (WVE) - GuruFocus
Wave Life Sciences director Rawcliffe sells $109k in stock By Investing.com - Investing.com South Africa
Wave Life Sciences director Rawcliffe sells $109k in stock - Investing.com India
Finanzdaten der Wave Life Sciences Ltd-Aktie (WVE)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.38%
1.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):